ArticleCancers2023

Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience.

Aaron Trando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.